logo
T1 TOLL-LIKE RECEPTOR 2 AGONIST AMELIORATES ESTABLISHED ALLERGIC AIRWAYS INFLAMMATION BY PROMOTING TH1 RESPONSE AND NOT VIA REGULATORY T CELLS
T2 ONCOSTATIN M: A NOVEL CYTOKINE IN TUBERCULOSIS THAT DRIVES TISSUE DESTRUCTION
T3 AIRWAY SMOOTH MUSCLE INDUCES HUMAN LUNG MAST CELL PROLIFERATION AND SURVIVAL
T4 THROMBIN INDUCED RELEASE OF ACTIVE TRANSFORMING GROWTH FACTOR-BETA FROM MESOTHELIAL CELL: A POTENTIAL MECHANISM OF ADHESION FORMATION IN PLEURAL INFECTION
T5 FUNCTIONAL IKCA1 K+ CHANNELS ARE REQUIRED FOR HUMAN LUNG MAST CELL MIGRATION TO CXCL10
T6 BRAIN NATRIURETIC PEPTIDE LEVELS PREDICT THE EXTENT OF RIGHT VENTRICULAR DYSFUNCTION, DETERMINED BY CARDIOVASCULAR MAGNETIC RESONANCE IMAGING, IN PATIENTS PRESENTING WITH PULMONARY HYPERTENSION
S1 INCREASED TACHYKININ LEVELS IN THE AIRWAYS OF ASTHMATIC PATIENTS AND CHRONIC COUGH PATIENTS WITH COEXISTENT GASTRO-OESOPHAGEAL REFLUX DISEASE
S2 CLINICAL AND PATHOLOGICAL FEATURES OF NON-EOSINOPHILIC ASTHMA: A DISTINCT ASTHMA PHENOTYPE ASSOCIATED WITH INHALED CORTICOSTEROID RESISTANCE
S3 MAST CELL MIGRATION TO TH2 STIMULATED AIRWAY SMOOTH MUSCLE FROM ASTHMATICS
S4 DELETERIOUS EFFECT OF DIESEL FINE PARTICULATE EXPOSURE IN OXFORD STREET ON ASTHMA
S5 THE PATHOLOGY OF SEVERE PRESCHOOL WHEEZE
S6 AIRWAY INFLAMMATION FOLLOWING SMOKING CESSATION IN ASTHMA
S7 THE ROLE OF PI3K/AKT IN HYPOXIC PROLIFERATION OF PULMONARY ARTERY SMOOTH MUSCLE CELLS
S8 A ROBUST GRADING SYSTEM FOR VASCULAR REMODELLING IN SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE LUNG RESECTIONS
S9 STATINS INHIBIT HYPOXIC PROLIFERATION OF PULMONARY ARTERY FIBROBLASTS: POTENTIAL FOR THE TREATMENT OF PULMONARY HYPERTENSION
S10 CHARACTERISATION OF THE VASODILATORY ACTION OF TESTOSTERONE IN THE HUMAN PULMONARY CIRCULATION
S11 CHARACTERISATION OF REGULATORY ELEMENTS IN THE BMPR2 GENE PROMOTER
S12 PROSPECTIVE STUDY OF THE VALUE OF BRONCHOSCOPY TO SCREEN FOR LUNG CANCER IN SMOKERS AND EX-SMOKERS AGED OVER 50 YEARS WITH PNEUMONIA
S13 THE VALUE OF TARGETED BRONCHIAL CYTOLOGY IN LUNG CANCER PATIENTS WITH A NORMAL BRONCHOSCOPY
S14 IMPACT OF A COORDINATED QUALITY IMPROVEMENT PROGRAMME UPON YIELD OF BRONCHOSCOPY IN SUSPECTED LUNG CANCER
S15 ENDOBRONCHIAL PALLIATION OF MALIGNANT AIRWAY OBSTRUCTION: THE EARLIER THE BETTER?
S16 ENDOBRONCHIAL TREATMENT OF CARCINOID TUMOURS: A COMPLEMENTARY APPROACH TO SURGERY
S17 THE NEW HOME OXYGEN SERVICE: ASSESSING THE IMPACT ON RESPIRATORY UNITS.
S18 EFFECT OF SHORT BURST OXYGEN THERAPY IN THE HOME ON RECOVERY FROM EXERCISE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A DOUBLE BLIND CROSSOVER STUDY
S19 A RANDOMISED CONTROLLED TRIAL TO ASSESS THE EFFECT OF HELIOX IN PATIENTS WITH EXACERBATIONS OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
S20 SUCCESS IN WARD OXYGEN PRESCRIPTION USING NOVEL APPROACH
S21 LOW OXYGEN SATURATIONS, HIGH FLYING PATIENTS, BUT ARE THEY FIT TO FLY?
S22 UPDATE ON BTS/BLF UK FLIGHT OUTCOMES STUDY
S23 ONE YEAR’S EXPERIENCE OF A CHEST RADIOGRAPH “SAFETY NET” PROTOCOL
S24 THE FREQUENCY OF CHEST X RAY ABNORMALITIES IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE SCREENING
S25 FIVE YEAR EXPERIENCE OF AN X RAY CODING SYSTEM IN LUNG CANCER DIAGNOSIS
S26 OUTCOME OF SMALL PULMONARY NODULES AT CHEST CT FROM A RAPID ACCESS LUNG CANCER CLINIC
S27 INITIAL EXPERIENCE WITH FDG-PET SCANS IN THE EVALUATION OF PATIENTS WITH LUNG CANCER
S28 THE UTILITY OF NEOSPECT SCANNING IN THE DIAGNOSIS OF SOLITARY PULMONARY NODULES: A DISTRICT GENERAL HOSPITAL EXPERIENCE
S29 A STUDY OF AIRWAY INFLAMMATION IN ACUTE SEVERE ASTHMA
S30 INDUCED SPUTUM GM-CSF CONCENTRATION IS INCREASED IN MODERATE AND SEVERE ASTHMA
S31 ASSESSING ASTHMA CONTROL: THE RCP 3 QUESTIONS CORRELATED WITH CLINICAL PARAMETERS AND EXHALED NTRIC OXIDE LEVELS
S32 AIRWAY INFLAMMATION IN ASTHMA IS ASSOCIATED WITH AN INCREASE IN RESPIRATORY HEAT AND MOISTURE LOSS
S33 EXHALED NITRIC OXIDE MONITORING IN COMMUNITY ASTHMA CLINICS: RELATION WITH ASTHMA CONTROL PARAMETERS
S34 REGIONAL VENTILATORY DEFECTS IN ASTHMA: REPRODUCIBLE IN STABLE ASTHMA
S35 CHEMOKINE PRODUCTION BY MOUSE LUNGS SUBJECTED TO INJURIOUS MECHANICAL VENTILATION REQUIRES EXTRACELLULAR REGULATED KINASE 1/2 PATHWAY ACTIVITY
S36 THE EXTRACELLULAR SIGNAL RELATED KINASE PATHWAY MEDIATES MECHANOTRANSDUCTION IN A549 CELLS
S37 STRETCH INDUCED PULMONARY OEDEMA IS MEDIATED BY TUMOUR NECROSIS FACTOR RECEPTOR I SIGNALLING IN MICE
S38 VASCULAR ENDOTHELIAL GROWTH FACTOR: NOT JUST AN ENDOTHELIAL CELL GROWTH FACTOR?
S39 DO BETA AGONISTS PROMOTE EPITHELIAL REPAIR?
S40 ESTABLISHMENT OF A WEB BASED RESEARCH TOOL, INFORMATION RESOURCE, AND PATIENT LED SUPPORT FORUM FOR RARE PAEDIATRIC RESPIRATORY DISEASE IN THE UK (THE BPOLD REGISTRY)
S41 HYGIENE HYPOTHESIS: A TEST WITHIN A UK BIRTH COHORT
S42 CORONA IONS FROM HIGH VOLTAGE POWER LINES ARE NOT ASSOCIATED WITH ADVERSE EFFECTS ON LUNG HEALTH, ASTHMA, OR ATOPY IN YOUNG CHILDREN: A LONGITUDINAL BIRTH COHORT STUDY
S43 DOES THE FALL IN CHILDHOOD ASTHMA PREVALENCE REFLECT FEWER RESPIRATORY TRACT INFECTIONS?
S44 ASSOCIATION OF ALVEOLAR MACROPHAGE CARBON LOADING AND ANNUAL MODELLED PM10 AT RESIDENCE IN HEALTHY CHILDREN
S45 COMPREHENSIVE ADOLESCENT ASTHMA SERVICE IMPROVES CLINICAL OUTCOMES
S46 PHASE I/II CLINICAL TRIAL OF MVA85A IN INDIVIDUALS WITH LATENT TUBERCULOSIS: THE FIRST SUBUNIT TB VACCINE IN CLINICAL TRIAL
S47 PROSPECTIVE STUDY OF PARADOXICAL REACTIONS IN TUBERCULOSIS PATIENTS
S48 MIRU-VNTR FINGERPRINTING OF M TUBERCULOSIS ISOLATES FROM EAST LANCASHIRE: 2001–05
S49 TRENDS IN INCIDENCE AND MICROBIOLOGICAL CONFIRMATION OF EXTRA PULMONARY TUBERCULOSIS IN ENGLAND AND WALES 1999–2003
S50 THE DIAGNOSIS OF ACTIVE TUBERCULOSIS AND THE ELISPOT TEST
S51 INCREASING TUBERCULOSIS IN ENGLAND AND WALES COMPARED WITH A DECREASING TREND IN THE USA: A MATTER OF MIGRATION
S52 RANDOMISED CROSSOVER TRIAL OF MECHANICAL IN-EXSUFFLATION PLUS NON-INVASIVE VENTILATION (NIV) ASSISTED CHEST PHYSIOTHERAPY VERSUS NIV ASSISTED PHYSIOTHERAPY ALONE IN NEUROMUSCULAR PATIENTS WITH AN ACUTE RESPIRATORY TRACT INFECTION
S53 SPONTANEOUS BREATHING TRIAL TO PREDICT THE DEGREE OF VENTILATOR DEPENDENCE IN PATIENTS WITH NEUROMUSCULAR DISEASE
S54 NON-INVASIVE VENTILATION AND CORTICOSPINAL PATHWAYS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
S55 NON-INVASIVE POSITIVE PRESSURE VENTILATION FOR ACUTE RESPIRATORY FAILURE: VALUE AS A CEILING THERAPY
S56 DOES LONG TERM DOMICILIARY NON-INVASIVE VENTILATION IMPROVE SURVIVAL IN SEVERE HYPERCAPNIC CHRONIC OBSTRUCTIVE PULMONARY DISEASE?
S57 EVALUATION OF THE TRANSER OF A CHRONIC VENTILATRY FAILURE SERVICE FROM A NATIONAL TO A LOCAL CENTRE
S58 ADAM33 IN EMBRYONIC LUNGS
S59 FUNCTIONAL ANALYSIS OF GSTP1 HAPLOTYPES ON CELL GROWTH AND APOPTOSIS IN NIH3T3 FIBROBLASTS
S60 ACTIVATION OF PAR1 BY FXA INDUCES FIBROBLAST TO MYOFIBROBLAST DIFFERENTIATION
S61 PAR1 SIGNALING IN LUNG EPITHELIAL CELLS INDUCES THE EXPRESSION OF CCL2/MCP-1 AND CTGF
S62 HUMAN HERPES VIRUS-8 K5 PROTEIN REDUCES CELL SURFACE EXPRESSION OF BONE MORPHOGENETIC PROTEIN TYPE II RECEPTOR
S63 THE PULMONARY INNATE IMMUNE RESPONSE TO PSEUDOMONAS AERUGINOSA INFECTION IN HUMAN LUNG TRANSPLANT RECIPIENTS
S64 PROGNOSTIC FACTORS IN HIV ASSOCIATED PNEUMOCYSTIS JIROVECII PNEUMONIA
S65 CASE MIX AND OUTCOME FOR ADULTS WITH COMMUNITY ACQUIRED PNEUMONIA ON THE INTENSIVE CARE UNIT: ANALYSIS OF THE ICNARC DATABASE
S66 LEGIONELLA URINARY ANTIGEN TESTING: WORTH ITS “WAIT” IN GOLD
S67 WHY ARE ANTIBIOTICS USED SO FREQUENTLY FOR ACUTE BRONCHITIS: CAN LESSONS BE LEARNT FROM THE PAST?
S68 ARE TELEPHONE CONSULTATIONS USEFUL IN RESPIRATORY OUTPATIENTS?
S69 HOW USEFUL DO PATIENTS FIND POST CONSULTATION LETTERS?
S70 ASSESSING RESPIRATORY PATIENTS KNOWLEDGE OF THEIR INHALED THERAPY
S71 PRIORITY INFORMATION NEEDS IN PARENTS OF CHILDREN WITH ASTHMA: RESULTS FROM A SURVEY USING A PAIRED COMPARISONS APPROACH
S72 LAY ASTHMA EDUCATORS KNOWLEDGE AND CONSULTATION STYLES
S73 OBSTACLES TO SELF MANAGEMENT IN BRONCHIECTASIS: THE PATIENTS’ PERSPECTIVE
S74 OSTEOCLAST FORMATION POTENTIAL FROM HAEMATOPOIETIC PRECURSORS IS ALTERED DURING INFECTIVE EXACERBATION IN ADULT CYSTIC FIBROSIS PATIENTS
S75 LONG TERM EFFECTS OF DIABETES AND INSULIN TREATMENT ON CLINICAL STATUS AND LUNG FUNCTION IN CYSTIC FIBROSIS
S76 RIGHT VENTRICULAR DIASTOLIC FUNCTION AND C-REACTIVE PROTEIN CIRCULATING LEVELS CORRELATE TO SURVIVAL IN ADULTS WITH CYSTIC FIBROSIS
S77 OUTCOMES OF CYSTIC FIBROSIS PATIENTS UNDERGOING INVASIVE VENTILATION ON THE INTENSIVE CARE UNIT
S78 PALLIATIVE CARE NEEDS OF PATIENTS WITH ADVANCED CYSTIC FIBROSIS
S79 CHANGE IN PRACTICE IN THE DIAGNOSIS OF LUNG CANCER IN GREENWICH 1998–2004
S80 LUNG CANCER CARE IN LIVERPOOL: REAUDIT EIGHT YEARS ON
S81 LUNG CANCER OUTCOMES AT A UK CANCER CENTRE: CAN WE DO BETTER?
S82 CANCER WAITING TIME TARGETS AND TUMOUR STAGE AT SURGERY FOR LUNG CANCER
S83 WHY DON’T WE OPERATE MORE? A STUDY OF NON-SMALL CELL CANCER IN A DEPRIVED INNER CITY AREA
S84 RANDOMISED TRIAL COMPARING CHEST DRAIN WITH INTRAPLEURAL UROKINASE VERSUS VIDEO ASSISTED THORACOSCOPIC SURGERY FOR THE TREATMENT OF EMPYEMA IN CHILDREN
S85 VIDEO ASSISTED THORACOSCOPIC SURGERY FOR CHRONIC POST-PNEUMONIC EMPYEMA: A MISSED OPPORTUNITY?
S86 THE SURVIVAL SIGNIFICANCE OF DIFFERENT BACTERIAL CLASSES IN PLEURAL INFECTION: DATA FROM THE MRC/BTS MIST1 TRIAL COHORT
S87 STUDY OF PLEURAL FLUID BIOCHEMISTRY: CAN ANION GAP BE A SURROGATE MARKER OF PH?
S88 THE CLINICAL UTILITY OF ULTRASOUND IN DETECTING MALIGNANT PLEURAL DISEASE IN THE PRESENCE OF A PLEURAL EFFUSION
S89 OUTPATIENT MANAGEMENT OF PNEUMOTHORAX
S90 SENSITIVITY TO ALTERNARIA ALTERNATA IN GRASS POLLEN SENSITIVE ASTHMATICS IS AN IMPORTANT FACTOR IN THUNDERSTORM OUTBREAKS OF ASTHMA
S91 CHILDHOOD OBESITY PREDICTS CURRENT INCIDENT ASTHMA IN ADULT WOMEN
S92 THE DIAGNOSTIC LABEL OF CHILDHOOD WHEEZY BRONCHITIS SHOULD BE REINSTATED
S93 HEALTH LOCUS OF CONTROL IN ADULTS WITH WELL AND POORLY CONTROLLED ASTHMA: A CASE CONTROL SURVEY
S94 HETEROGENEITY IN REFRACTORY ASTHMA: THE USE OF CLUSTER ANALYSIS TO IDENTIFY DISTINCT COHORTS
S95 PSYCHOSOCIAL CORRELATES OF PREVALENT ASTHMA AND OF INCIDENT HOSPITAL ADMISSIONS DUE TO ASTHMA: EVIDENCE FROM THE EPIC-NORFOLK POPULATION BASED COHORT OF OLDER ADULTS
S96 EFFICACY AND ORGANISATION OF EARLY DISCHARGE SCHEMES FOR ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE: ANALYSIS FROM THE 2ND UK COPD AUDIT
S97 THE WARM STUDY: A CASE CONTROL STUDY OF THE RISK FACTORS FOR HOSPITAL ADMISSION IN THE WINTER AMONG THE ELDERLY WITH ACUTE RESPIRATORY DISEASE
S98 FACTORS AFFECTING SURVIVAL AFTER A HOSPITAL ADMISSION FOR AN EXACERBATION OF RESPIRATORY SYMPTOMS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
S99 CHRONIC OBSTRUCTIVE PULMONARY DISEASE MORTALITY: A 360 DEGREE ANALYSIS
S100 NON-ACIDOTIC CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS REQUIRING HOSPITAL ADMISSION: WHAT HAPPENS TO PATIENTS FIVE YEARS ON?
S101 PERCEIVED SAFETY OF NICOTINE REPLACEMENT PRODUCTS AMONG GENERAL PRACTITIONERS IN THE UK: IMPACT ON UTILISATION
S102 CUTTING DOWN SMOKING THEN STOPPING WITH NICOTINE REPLACEMENT THERAPY: AN INNOVATIVE APPROACH TO SMOKING CESSATION
S103 SMOKING ATTITUDES OF HOSPITAL STAFF: A FOLLOW UP SURVEY
S104 SMOKING CESSATION IS ASSOCIATED WITH A SUSTAINED INCREASE IN BODY MASS INDEX
S105 WHERE DO SMOKERS PREFER THEIR SMOKING CESSATION SERVICE TO BE BASED?
S106 TEENAGE SMOKING IN HOSPITALS: A SURVEY OF ALL WELSH PAEDIATRIC UNITS
S107 POSITIVE SPECIFIC BRONCHIAL CHALLENGES DESPITE NORMAL BRONCHIAL HYPERRESPONSIVENESS
S108 CROSS SHIFT CHANGES IN FEV1 BEST PREDICT WORK RELATED RESPIRATORY SYMPTOMS IN TEXTILE WORKERS
S109 FALL IN THE INCIDENCE OF OCCUPATIONAL ASTHMA FOLLOWING AN INTERVENTION IN A DETERGENT ENZYME FACTORY
S110 THE RESPONSE OF HUMAN ALVEOLAR MACROPHAGES TO THE STIMULI OF COTTON DUST AND CYCLIC PRESSURE
S111 NON-INVASIVE MEASUREMENT OF MARKERS OF OXIDATIVE STRESS IN ASBESTOS INDUCED LUNG DISEASE
S112 INVESTIGATION OF AN OUTBREAK OF ALVEOLITIS IN A CAR ENGINE MANUFACTURING PLANT
S113 SCREENING QUESTIONNAIRES IN PATIENTS REFERRED TO A SLEEP CLINIC CANNOT PREDICT WHICH INDIVIDUALS DO NOT REQUIRE CONTINUOUS POSITIVE AIRWAY PRESSURE TREATMENT FOR OBSTRUCTIVE SLEEP APNOEA
S114 DAYTIME ACTIVITY LEVELS AND SLEEP FRAGMENTATION IN MILD TO MODERATE CONGESTIVE HEART FAILURE PATIENTS WITH SLEEP DISORDERED BREATHING
S115 ACUTE CARDIOVASCULAR RESPONSE TO AROUSAL IN OBSTRUCTIVE SLEEP APNOEA BEFORE AND AFTER CONTINUOUS POSITIVE AIRWAY PRESSURE TREATMENT
S116 PATIENTS WITH OBSTRUCTIVE SLEEP APNOEA HAVE IMPAIRED CARDIAC METABOLISM AND DIASTOLIC DYSFUNCTION COMPARED TO CONTROLS
S117 RANDOMISED CONTROLLED TRIAL EVIDENCE THAT CONTINUOUS POSITIVE AIRWAY PRESSURE IMPROVES VASCULAR FUNCTION IN OBSTRUCTIVE SLEEP APNOEA HYPOPNOEA SYNDROME
S118 THE EFFECT OF SIBUTRAMINE INDUCED WEIGHT LOSS ON SLEEP APNOEA SEVERITY AND METABOLIC PARAMETERS IN OBESE MEN
S119 EVIDENCE OF A ROLE FOR TNFα IN REFRACTORY ASTHMA
S120 EFFECT OF ROFLUMILAST ON LUNG FUNCTION AND EXACERBATIONS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: RESULTS OF A ONE YEAR STUDY
S121 PRESCRIBING OF HIGH DOSE INHALED CORTICOSTEROIDS AND ADD-ON THERAPY IN CHILDREN FROM 1999–2004: AN OBSERVATIONAL STUDY
S122 AN OBSERVATIONAL INVESTIGATION OF HYPERVENTILATION AND BREATHING CONTROL THERAPY IN A PROBLEM ASTHMA CLINIC
S123 EFFICACY OF CICLESONIDE IN SMOKERS AND NON-SMOKERS WITH ASTHMA
S124 EFFICACY AND SAFETY OF ONCE-DAILY CICLESONIDE 160 μG AS COMPARED WITH ONCE-DAILY BUDESONIDE 400 μG IN PAEDIATRIC ASTHMA PATIENTS
S125 MYCOBACTERIAL HEAT SHOCK PROTEIN 70 TRIGGERS RAPID DENDRITIC CELL-T CELL IMMUNE SYNAPSE FORMATION VIA THE CHEMOKINE RECEPTOR CCR5
S126 VITAMIN D ENHANCES ANTIMYCOBACTERIAL IMMUNITY IN VIVO AND IN VITRO
S127 MONOCYTE FIBROBLAST NETWORKS DRIVE MATRIX DEGRADATION IN TUBERCULOSIS
S128 MESSENGER RNA AS A MARKER OF TREATMENT RESPONSE IN PULMONARY TUBERCULOSIS
S129 SPUTUM INDUCTION IS A NON-INVASIVE ALTERNATIVE TO BAL ALLOWING A LUNG ORIENTATED APPROACH TO INVESTIGATE IMMUNE RESPONSES IN PATIENTS WITH TUBERCULOSIS
S130 LOCALISATION OF ADAM33 TO BRONCHIAL SMOOTH MUSCLE IN ASTHMATIC AIRWAYS AND HUMAN EMBRYONIC LUNGS
S131 MICRO ARRAY ANALYSIS OF REGENERATING ADULT MOUSE LUNG
S132 RETINOID INDUCTION OF ALVEOLAR REGENERATION IN A MOUSE MODEL OF EMPHYSEMA
S133 DIFFERENTIAL EXPRESSION OF P63 AND CYTOKERATINS IN “CUBOIDAL” AND “SQUAMOUS” EPITHELIAL METAPLASIA FROM ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE SUBJECTS
S134 MURINE MESENCHYMAL STEM CELLS GENERATE OSTEOSARCOMA-LIKE LESIONS IN THE LUNG: IMPLICATIONS FOR STEM CELL THERAPY
S135 THE USE OF PREDICTED POST OPERATIVE LUNG FUNCTION TO PREDICT DURATION OF INTENSIVE CARE UNIT ADMISSION FOLLOWING PULMONARY RESECTION FOR MALIGNANCY
S136 THE STRENGTH OF BRITISH THORACIC SOCIETY GUIDELINES IN DETERMINING THE OUTCOME FOR LUNG CANCER SURGERY: BIRMINGHAM HEARTLANDS HOSPITAL’S EXPERIENCE
S137 PREOPERATIVE PREDICTORS OF PROLONGED AIR LEAK FOLLOWING LOBECTOMY FOR PRIMARY LUNG CANCER
S138 THE ROLE OF MEDIASTINOSCOPY IN THE SELECTION FOR EXTRAPLEURAL PNEUMONECTOMY IN MALIGNANT MESOTHELIOMA
S139 NEOADJUVANT AND ADJUVANT CHEMOTHERAPY IN A RADICAL TREATMENT PROTOCOL FOR MALIGNANT MESOTHELIOMA WITH EXTRAPLEURAL PNEUMONECTOMY
S140 AN INNOVATIVE, AUTOCLAVABLE, SEMIRIGID THORACOSCOPE: IS THIS THE WAY FORWARD?
S141 FACTORS INFLUENCING SUCCESS OF ACHIEVING LUNG TRANSPLANTATION IN PATIENTS WITH PULMONARY FIBROSIS PLACED ON THE WAITING LIST 1999–2004
S142 FIBROSING ALVEOLITIS IN SCLERODERMA TRIAL (FAST): A MULTICENTRE PROSPECTIVE RANDOMISED DOUBLE BLIND PLACEBO CONTROLLED TRIAL
S143 OUTCOMES OF PULMONARY RENAL SYNDROME IN PATIENTS WITH ANCA ASSOCIATED VASCULITIS
S144 ASSOCIATION BETWEEN THE GENOTYPE OF THE TNF LOCUS AND ACUTE REJECTION FOLLOWING LUNG TRANSPLANT
S145 THE F2R (PROTEINASE ACTIVATED RECEPTOR-1) -506INS POLYMORPHISM ASSOCIATES WITH SUSCEPTIBILITY TO SARCOIDOSIS IN TWO POPULATIONS
S146 QUADRICEPS MUSCLE ENDURANCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: CORRELATION WITH MUSCLE BIOPSY DATA
S147 QUADRICEPS STRENGTH PREDICTS MORTALITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
S148 LIMB AND INSPIRATORY MUSCLE DYNAMIC STRENGTH IN PATIENTS WITH MODERATE CHRONIC OBSTRUCTIVE PULMONARY DISEASE
S149 THORACO-ABDOMINAL ASYNCHRONY BETTER PREDICTS EXERCISE TOLERANCE THAN FEV1 IN PATIENTS WITH SEVERE PERSISTENT ASTHMA
S150 INSPIRATORY LUNG FUNCTION MEASUREMENTS CORRELATE WITH MRC BREATHLESSNESS SCORE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS
S151 BTS STUDY OF THREE VERSUS SIX MONTHS’ ANTICOAGULATION FOR PULMONARY VENOUS THROMBOEMBOLISM
S152 DIAGNOSIS AND TREATMENT OF PULMONARY EMBOLISM: FINDINGS FROM THE VERITY VTE TREATMENT REGISTRY
S153 CAN THE USE OF BTS PULMONARY EMBOLISM GUIDELINES HELP IN REDUCING UNNECESSARY CT PULMONARY ANGIOGRAM SCANNING?
S154 THE UTILITY OF MULTISLICE COMPUTED TOMOGRAPHIC PULMONARY ANGIOGRAPHY IN THE DIAGNOSIS OF PULMONARY EMBOLISM: A REVIEW OF 800 CASES FROM A DISTRICT GENERAL HOSPITAL
S155 OUTPATIENT TREATMENT OF PATIENTS WITH PULMONARY EMBOLISM: RESULTS OF AN OBSERVATIONAL STUDY
S156 PULMONARY EMBOLISM AND PULMONARY HYPERTENSION: IS OUR FOLLOW UP ADEQUATE?
P1 SYMPTOMS IN LUNG CANCER: DO THEY HELP THE DIAGNOSIS?
P2 NO SYMPTOM AWARENESS IN SALFORD LUNG CANCER PATIENTS: THE NEED FOR A PUBLIC HEALTH AWARENESS CAMPAIGN
P3 WORDING OF CHEST X RAY REPORTS CODED AS “POSSIBLE LUNG CANCER”
P4 VARIATION BETWEEN CHEST PHYSICIANS AND ONCOLOGISTS IN MEASUREMENT OF PERFORMANCE STATUS OF PATIENTS WITH NON-SMALL CELL LUNG CANCER
P5 THE THIRD WAVE: AN UPDATED META-ANALYSIS OF POSTOPERATIVE CHEMOTHERAPY FOR NON-SMALL CELL LUNG CANCER USING CISPLATIN BASED REGIMENS
P6 CAVITATING NON-SMALL CELL LUNG CANCER: DOES IT REPRESENT A MORE AGGRESSIVE DISEASE?
P7 HOMOCYSTEINE LEVELS IN NEWLY DIAGNOSED PATIENTS WITH NON-SMALL CELL LUNG CANCER
P8 PULMONARY FUNCTION TESTING AS PREDICTORS OF POSTOPERATIVE COMPLICATIONS AND PROLONGED HOSPITALISATION AFTER LUNG RESECTION.
P9 TIDAL BREATHING AT RESIDUAL VOLUME MAY BE ASSOCIATED WITH SEVERE ASTHMA
P10 NON-ADHERENCE REMAINS A MAJOR PROBLEM IN DIFFICULT ASTHMA
P11 PATTERN OF SUPPRESSION OF EXHALED NITRIC OXIDE AFTER INTRAMUSCULAR TRIAMCINALONE IN DIFFICULT PAEDIATRIC ASTHMA
P12 WITHDRAWN
P13 CATEGORISING THE ASTHMA PHENOTYPE: RESULTS OF A FACTOR ANALYSIS
P14 EVALUATING ASTHMA CONTROL
P15 GLOBAL ASTHMA PHYSICIAN AND PATIENT (GAPP) SURVEY: PATIENT EDUCATION AND PATIENT-PHYSICIAN COMMUNICATIONS—UK FINDINGS
P16 PATTERNS OF AIRFLOW LIMITATION IN PATIENTS WITH A PRIMARY CARE DIAGNOSIS OF ASTHMA AND THEIR RELATION WITH EOSINOPHILIC INFLAMMATION
P17 DIFFICULT ASTHMA IN THE UK: A NATIONAL SURVEY OF APPROACHES TO MANAGEMENT AND AVAILABLE SERVICES
P18 GLOBAL ASTHMA PHYSICIAN AND PATIENT (GAPP) SURVEY: TREATMENT LIMITATIONS—UK FINDINGS
P19 ADMINISTRATION OF INHALED INSULIN TO PATIENTS WITH TYPE 1 DIABETES IS NOT ASSOCIATED WITH AIRWAY HYPERRESPONSIVENESS
P20 SECONDARY CARE IMPLEMENTATION OF STEPPING-DOWN INHALED CORTICOSTEROID THERAPY IN STABLE ASTHMA
P21 THE ECONOMIC AND HUMAN IMPACT OF POOR CONTROL IN PATIENTS WITH SEVERE PERSISTENT ALLERGIC ASTHMA: RESULTS FROM A MULTINATIONAL STUDY
P22 COMPUTER ASSISTED LEARNING IS A USEFUL TOOL TO TEACH FINAL YEAR MEDICAL UNDERGRADUATES THE PRINCIPLES OF SPIROMETRY
P23 MANAGEMENT OF LUNG CANCER: IS IT AFFECTED BY THE SOURCE OF REFERRAL?
P24 THE EFFECT OF THE LUNG INVESTIGATION DAY ON THE TIME TAKEN TO DIAGNOSE LUNG CANCER
P25 AGE AND STAGE AT PRESENTATION IN LUNG CANCER
P26 GENERAL PRACTICE UTILISATION OF A RAPID ACCESS LUNG CANCER CLINIC IN LIVERPOOL
P27 IS THE TWO WEEK WAIT GENERIC CANCER REFERRAL FORM OF ANY USE?
P28 THE VALUE OF LUNG CANCER MULTIDISCIPLINARY TEAM MEETINGS: DID PATIENTS ACTUALLY RECEIVE TREATMENT AS AGREED IN THOSE MEETINGS?
P29 INCIDENCE OF LUNG CANCER IN AN EAST LONDON BOROUGH OVER FIVE YEARS SINCE APRIL 2000
P30 PILOT STUDY COMPARING THREE DIFFERENT METHODS OF FLIGHT ASSESSMENT USING HYPOXAEMIC NORMOBARIC CHALLENGES
P31 A NATIONAL AUDIT OF FITNESS TO FLY ASSESSMENTS
P32 MODELLING THE ANNUAL NEED FOR LONG TERM OXYGEN THERAPY ASSESSMENTS AND AMBULATORY OXYGEN ASSESSMENTS FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS IN LEEDS
P33 CURRENT PATTERNS OF REPORTED OXYGEN USE AND ACTIVITY OF PATIENTS USING LONG TERM OXYGEN THERAPY VIA A CONCENTRATOR
P34 VALUE OF AN OXYGEN REGISTER IN IDENTIFYING PATIENTS ELIGIBLE TO RECEIVE LONG TERM OXYGEN THERAPY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P35 THE EFFECT OF AMBULATORY OXYGEN IN PATIENTS DURING PULMONARY REHABILITATION
P36 CLOSING THE LOOP: AN ONGOING AUDIT OF THE PRESCRIPTION AND FOLLOW UP OF PATIENTS RECEIVING LONG TERM OXYGEN THERAPY IN SOUTH DEVON
P37 OXYGEN PRESCRIPTION BY TARGET SATURATION: RESULTS OF A PILOT PROJECT
P38 AN AUDIT OF LONG TERM OXYGEN THERAPY IN WOLVERHAMPTON: IMPLICATIONS FOR THE NEW OXYGEN GUIDELINES
P39 RECOGNITION OF DIFFERENT OXYGEN DELIVERY SYSTEMS FOR DIFFERENT CLINICAL SCENARIOS BY HEALTHCARE PROFESSIONALS
P40 DOES BODY MASS INDEX INFLUENCE THE OUTCOME OF PULMONARY REHABILITATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE?
P41 IS OUTCOME IN PUMONARY REHABILITATION RELATED TO BODY MASS INDEX?
P42 EVALUATION OF AN ACTIVITY MANAGEMENT (BETTER BREATHING) CLINIC RUN BY OCCUPATIONAL THERAPY FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P43 DOES A PHYSIOTHERAPIST LED COMMUNITY BASED DISEASE MANAGEMENT PROGRAMME IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS AFFECT HOSPITAL ADMISSIONS WITH ACUTE EXACERBATIONS?
P44 OCCUPATIONAL THERAPY INTERVENTION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P45 IS LONGER BETTER? A COMPARISON OF SIX AND EIGHT WEEK COMMUNITY OUTPATIENT PULMONARY REHABILITATION PROGRAMMES
P46 FACTORS ASSOCIATED WITH SUCCESS AND FAILURE OF PULMONARY REHABILITATION
P47 THE EFFECT OF ANXIETY AND DEPRESSION ON THE BENEFITS OF PULMONARY REHABILITATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P48 AN ANXIETY MANAGEMENT PROGRAMME FOR PATIENTS WITH SEVERE OBSTRUCTIVE AIRWAYS DISEASE
P49 HOSPITAL READMISSION FROM A RESPIRATORY OUTREACH SERVICE AND DISCHARGE CRITERIA
P50 DROPOUTS FROM A PULMONARY REHABILITATION PROGRAMME
P51 REVIEWING SIX YEARS’ EXPERIENCE OF PULMONARY REHABILITATION AT THE ROYAL VICTORIA INFIRMARY
P52 THE RESPONSIVENESS OF THE LONDON CHEST ACTIVITY OF DAILY LIVING TO PULMONARY REHABILITATION
P53 IMPROVING EXACERBATION REPORTING BEHAVIOUR IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P54 AUDIT OF NON-INVASIVE VENTILATION IN PATIENTS WITH SEVERE RESPIRATORY ACIDOSIS (PH <7.25): EFFECT OF SETTING
P55 THE TWO YEAR SURVIVAL FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE WHO UNDERGO NON-INVASIVE VENTILATION FOR HYPERCAPNIC RESPIRATORY FAILURE
P56 NINETY DAY OUTCOMES IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS ADMITTED WITH SEVERE RESPIRATORY ACIDOSIS
P57 LONGITUDINAL STUDY OF BODY COMPOSITION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVER AN 18 MONTH PERIOD
P58 COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ITS INFLUENCE ON ADMISSION TO HOSPITAL
P59 A SIMPLE MULTIDIMENSIONAL STRATIFICATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE PREDICTS MORTALITY IN PATIENTS IDENTIFIED IN PRIMARY CARE
P60 COMPARISON OF PARTICIPANTS AND REFUSERS INVITED TO ENROL IN A CASE MANAGEMENT STUDY FOR PATIENTS WITH MODERATE TO SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P61 DO CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS UNDERSTAND THEIR DISEASE?
P62 THE LAST YEAR OF LIFE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE: THE CARERS’ PERSPECTIVE
P63 PSYCHOLOGICAL IMPACT OF MOODS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P64 OCCUPATIONAL ASTHMA: OLD AGENTS IN NEW (DIS)GUISES
P65 FACTORY EMPLOYMENT RATE AS A MAJOR DETERMINANT OF OCCUPATIONAL ASTHMA
P66 VARIATION IN DIAGNOSTIC METHODS FOR OCCUPATIONAL ASTHMA. A NATIONAL STUDY
P67 PREVALENCE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THE EFFECT OF OCCUPATIONAL EXPOSURES UPON LUNG FUNCTION IN NORTHEAST ENGLAND
P68 FEV1 DECLINE IN GRAIN EXPOSED WORKERS
P69 EXTRINSIC ALLERGIC ALVIOLITS ASSOCIATED WITH METAL WORKING FLUIDS IN A PRECISION ENGINEERING COMPANY
P70 POPULATION BASED EPIDEMIOLOGY AND PROGNOSIS OF MESOTHELIOMA IN LEEDS, UK
P71 SECONDARY CARE DIAGNOSIS OF OCCUPATIONAL LUNG DISEASE: ARE WE DOING ENOUGH?
P72 PILOTING A SURVEILLANCE SCHEME FOR OCCUPATIONAL AIRWAYS DISEASE IN SCOTLAND: SCOTTISHSHIELD
P73 CLINICAL UTILITY OF THE HYPNOPTT IN THE ASSESSMENT OF SLEEP APNOEA/HYPOPNOEA SYNDROME
P74 A COMPARISON OF TWO RESPIRATORY SIGNALS IN THE MEASUREMENT OF SLEEP DISORDERED BREATHING
P75 A COMPARISON BETWEEN TRANSCUTANEOUS MONITORING (TOSCA 500 SYSTEM) AND ARTERIALISED EAR LOBE BLOOD GAS SAMPLING FOR THE MEASUREMENT OF CARBON DIOXIDE LEVEL DURING THE SET UP PROCEDURE FOR PATIENTS REQUIRING LONG TERM NON-INVASIVE VENTILATION
P76 SYMPTOMS OF SLEEPINESS AND BREATHING PAUSES IN PROFESSIONAL SCOTTISH BUS DRIVERS
P77 SERUM ANGIOTENSIN CONVERTING ENZYME IS CORRELATED WITH NOCTURNAL DIASTOLIC BLOOD PRESSURE IN PATIENTS WITH THE SLEEP APNOEA SYNDROME
P78 INITIAL PATIENT PARAMETERS IN THOSE COMPLIANT WITH CPAP THERAPY FOR OBSTRUCTIVE SLEEP APNOEA SYNDROME AFTER ONE YEAR
P79 AUTOTITRATING CPAP FOR TREATING OBSTRUCTIVE SLEEP APNOEA: A BIMODAL RESPONSE
P80 PREVIOUSLY UNDIAGNOSED OBESITY HYPOVENTILATION SYNDROME: AN INCREASINGLY IMPORTANT CAUSE OF ACUTE ON CHRONIC RESPIRATORY FAILURE IN EMERGENCY ADMISSIONS
P81 IS THE PRESENCE OF THE METABOLIC SYNDROME A PREDICTOR OF DISEASE SEVERITY IN OBSTRUCTIVE SLEEP APNOEA SYNDROME?
P82 THE EFFECT OF MANDIBULAR ADVANCEMENT SPLINTS ON STEERING SIMULATION IN OBSTRUCTIVE SLEEP APNOEA SYNDROME: PRELIMINARY RESULTS
P83 DO HEALTH RELATED QUALITY OF LIFE IMPROVEMENTS OVER A TWO WEEK HOME CONTINUOUS POSITIVE AIRWAY PRESSURE TRIAL FOR OBSTRUCTIVE SLEEP APNOEA PREDICT LONG TERM COMPLIANCE?
P84 PROGNOSIS FOLLOWING INITIATION OF NON-INVASIVE VENTILATION IN PATIENTS WITH OBESITY HYPOVENTILATION SYNDROME IN A TERTIARY CENTRE
P85 LONGITUDINAL PROTEOMIC ANALYSIS OF SPONTANEOUS SPUTUM TO ASSESS LUNG INFLAMMATION IN CYSTIC FIBROSIS
P86 METHYLATION AND CONSERVATION ANALYSIS OF CPG ISLANDS IN THE ADAM33 GENE
P87 CODON 178 GENETIC POLYMORPHISM OF THE DNA REPAIR PROTEIN O6-METHYLGUANINE-DNA METHYLTRANSFERASE AND LUNG CANCER
P88 A NOVEL CYCLOOXYGENASE-2 VARIANT, -607T>C, ASSOCIATES WITH SUSCEPTIBILITY TO SARCOIDOSIS IN AFRO-CARIBBEANS
P89 IDENTIFICATION OF PAR1-G PROTEIN SIGNALING PATHWAYS INVOLVED IN THROMBIN INDUCED CCL2 RELEASE
P90 THE POTENTIAL ROLE OF INTERLEUKIN-17 IN AIRWAY INFLAMMATION AND REMODELLING IN POST-TRANSPLANT OBLITERATIVE BRONCHIOLITIS
P91 THE DIVERGENT EFFECTS OF HEME ON NEUTROPHIL APOPTOSIS
P92 HUMAN SQUAMOUS CELL CARCINOMA CELL LINES CONTAIN A SELECTABLE SIDE POPULATION THAT IS CELL CYCLE DEPENDENT BUT IS NOT A CANCER STEM CELL POPULATION
P93 SERUM LIPIDS IN PIGEON FANCIERS’ HYPERSENSITIVITY PNEUMONITIS: A PLACE FOR STATINS?
P94 PROBLEMS WITH INHALED THERAPY IN ELDERLY CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS: TIME FOR RE-EVALUATION?
P95 ASSESSMENT OF INHALER TECHNIQUE AND PATIENT INHALER IDENTIFICATION ON AN ACUTE ADMISSION UNIT
P96 TWO YEAR EFFICACY AND PULMONARY SAFETY OF INHALED INSULIN IN PATIENTS WITH TYPE 2 DIABETES UNCONTROLLED WITH ORAL AGENTS
P97 INVESTIGATION OF THE EFFECT OF INSULIN ON HUMAN AIRWAY EPITHELIAL ION TRANSPORT IN VIVO
P98 EFFECT OF NON-INVASIVE VENTILATION ON BRONCHODILATOR DELIVERY
P99 SAFETY AND TOLERABILITY OF TIOTROPIUM ADMINISTRATION TO THE EYES IN HEALTHY MALE VOLUNTEERS, SIMULATING INADVERTENT EXPOSURE FROM AN INHALER
P100 TIOTROPIUM: IS IT MORE COST EFFECTIVE THAN NEBULISERS IN AN EVERYDAY SETTING?
P101 THE EFFECT OF LEVOFLOXACIN ON NEUTROPHILIC AIRWAY INFLAMMATION IN STABLE STATE CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A RANDOMISED, DOUBLE BLIND, PLACEBO CONTROLLED TRIAL
P102 NEUTROPHIL ADHESION MOLECULES IN AN EXPERIMENTAL MODEL OF RHINOVIRUS INDUCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATION
P103 SERUM INTERLEUKIN 6 AT CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATION AND SUBSEQUENT HOSPITALISATION
P104 VIRAL INFECTION AND CYTOKINE RESPONSES IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P105 IN VITRO MODEL OF RHINOVIRUS INFECTION OF PRIMARY BRONCHIAL EPITHELIAL CELLS FROM SMOKERS
P106 HUMAN RHINOVIRUS UPREGULATES ICAM-1 EXPRESSION ON CULTURED NASAL EPITHELIAL CELLS FROM PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P107 RELATION BETWEEN RESPIRATORY SYNCYTIAL VIRUS DETECTION AND AIRWAY INFLAMMATION IN PATIENTS WITH STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P108 STUDIES OF INTERLEUKIN-1β AND ITS RECEPTOR IL-1 RECEPTOR 2 AND ANTAGONIST IL-1 RECEPTOR ANTAGONIST IN STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P109 ESTABLISHING PRIMARY CULTURES OF NASAL EPITHELIAL CELLS FROM NASAL BRUSHINGS
P110 MECHANISMS UNDERLYING ASSOCIATION BETWEEN HYPERGLYCAEMIA AND AIRWAY INFECTION IN PATIENTS WITH ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P111 REPEATABILITY OF INDUCED SPUTUM CHARCTERISTICS, SYMPTOMS, AND HEALTH STATUS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P112 DETERMINATION OF THE PREVALENCE OF ELEVATED SERUM TROPONIN T LEVELS IN SEVERE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE REQUIRING NON-INVASIVE VENTILATION AND ITS USE AS A PROGNOSTIC MARKER
P113 HYPERGLYCAEMIA IS ASSOCIATED WITH POOR OUTCOMES IN PEOPLE ADMITTED TO HOSPITAL WITH ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P114 CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND A FASTER DECLINE IN FEV1 ARE STRONGLY ASSOCIATED WITH HIGH SENSITIVITY C-REACTIVE PROTEIN: A MULTICENTRE EPIDEMIOLOGICAL STUDY
P115 HAEMOLYTIC DISORDERS COMPLICATED BY PULMONARY HYPERTENSION
P116 A SURVEY OF THE NEEDS AND IMPACT OF PULMONARY HYPERTENSION IN 2004 AND 2005 OF PATIENTS IN THE UK
P117 ABNORMAL POST-EXERCISE SYSTOLIC BLOOD PRESSURE RESPONSE TO EXERCISE IS COMMON IN PATIENTS WITH SUSPECTED PULMONARY HYPERTENSION
P118 HISTOLOGY OF ARTERIOLAR WALL REMODELLING IN A LUNG VOLUME REDUCTION SURGERY PATIENT COHORT
P119 LONG TERM EXPERIENCE WITH BOSENTAN FOR THE TREATMENT OF IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION UNDER ROUTINE CONDITIONS
P120 BOSENTAN FOR THE TREATMENT OF DISTAL CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: OUTCOMES AT ONE YEAR
P121 TREATMENT OF PULMONARY ARTERIAL HYPERTENSION IN ASSOCIATION WITH SYSTEMIC TO PULMONARY SHUNTS: A RETROSPECTIVE REVIEW
P122 DIAGNOSTIC UTILITY OF NYCOCARD D-DIMER ASSAY IN PULMONARY EMBOLISM
P123 COMPUTED TOMOGRAPHY PULMONARY ANGIOGRAM REQUESTS FOR THE INVESTIGATION OF ACUTE PULMONARY EMBOLI. HOW APPROPRIATE ARE THEY?
P124 LACK OF CLINICAL PROBABILITY ASSESSMENT IN PATIENTS INVESTIGATED FOR PULMONARY EMBOLISM
P125 PULMONARY EMBOLIC DISEASE: A PROTOCOL WITH THE APPROPRIATE USE OF CLINICAL PROBABILITY AND D-DIMER IS FEASABLE AND SAFE IN THE INVESTIGATION OF SUSPECTED PULMONARY ENBOLUS, IN THE SETTING OF A DISTRICT GENERAL HOSPITAL
P126 PREVALENCE OF ANXIETY AND DEPRESSION IN ADULTS WITH CYSTIC FIBROSIS
P127 UTILITY OF IMPULSE OSCILLOMETRY IN PREDICTING GAS TRAPPING IN CYSTIC FIBROSIS
P128 ROUTINE PLANER SCINIGRAPHY TO DETERMINE THE MOST APPROPRIATE NEBULISER FOR CYSTIC FIBROSIS PATIENTS
P129 TOBROMYCIN NEBULISER SOLUTION IN THE TREATMENT OF CYSTIC FIBROSIS PULMONARY EXACERBATIONS: EFFECT ON SPUTUM PSEUDOMONAS AERUGINOSA DENSITY
P130 IMPACT OF RESPIRATORY VIRUSES IN CYSTIC FIBROSIS
P131 PROINFLAMMATORY CYTOKINES IN ADULT CYSTIC FIBROSIS PATIENT IN A STABLE STATE AND DURING PULMONARY EXCAERBATIONS
P132 DETECTION OF INCREASED GLUCOSE CONCENTRATIONS IN LOWER AIRWAY SECRETIONS FROM PEOPLE WITH CYSTIC FIBROSIS
P133 CD14+CD16+ BLOOD MONOCYTES IN CYSTIC FIBROSIS
P134 CONTROL OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS AT A LARGE CYSTIC FIBROSIS CENTRE
P135 THE FUNCTION AND FATE OF NEUTROPHILS IN CYSTIC FIBROSIS
P136 NATIONAL UNITED KINGDOM SURVEY OF CYSTIC FIBROSIS PULMONARY EXACERBATION: MANAGEMENT VARIATION AMONGST PAEDIATRIC AND ADULT PHYSICIANS
P137 AIR POLLUTANTS, SEASONAL VARIATION, AND PULMONARY EXACERBATIONS IN A COHORT OF ADULT CYSTIC FIBROSIS PATIENTS
P138 UPTAKE OF BRITISH THORACIC SOCIETY GUIDELINES IN HOSPITALS IN THE EASTERN REGION
P139 IMPACT OF PRIMARY CARE TRUST BASED CHRONIC OBSTRUCTIVE PULMONARY DISEASE TEAMS AT REDUCING HOSPITAL ADMISSIONS IN LEEDS IN 2003 AND 2004
P140 CONFIDENCE AND UNDERSTANDING AMONG GENERAL PRACTITIONERS AND PRACTICE NURSES ABOUT DIAGNOSIS AND MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P141 THE DEVELOPMENT OF A TIER 2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE SERVICE IN STOCKPORT
P142 MANAGEMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE BEFORE ADMISSION: FAILINGS IN PRIMARY CARE
P143 A PROTOCOL DRIVEN NURSE LED CLINIC LEADS TO COST SAVINGS AND SHORTER WAITING TIMES FOR ROUTINE RESPIRATORY REFERERALS
P144 MULTIDISCIPLINARY WORKING IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: IS IT WORTH IT?
P145 CHARACTERISTIS OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE WHO REPEATEDLY ATTEND THE ACCIDENT AND EMERGENCY DEPARTMENT DESPITE A CHRONIC RESPIRATORY SUPPORT SERVICE
P146 DEFINING CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY A NEW COMMUNITY SPIROMETRY SERVICE IN LIVERPOOL
P147 USE OF COMPLEMENTARY AND ALTERNATIVE THERAPIES BY PATIENTS ATTENDING A CHEST CLINIC
P148 HEALTHCARE NEEDS ASSESSMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE SERVICES IN TRAFFORD
P149 USING POPULATION IMPACT MEASURES IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE FOR PRIORITISATION OF RESOURCES IN TRAFFORD
P150 SHOULD MEDIASTINOSCOPY BE PERFORMED ROUTINELY FOR MEDIASTINAL NYMPH NODES WHEN TUBERCULOSIS IS SUSPECTED?
P151 IMPORTANCE OF ACCURATE CLASSIFICATION OF DEATHS IN PATIENTS WITH TUBERCULOSIS
P152 HOW IS PERIPHERAL LYMPH NODE TUBERCULOSIS MANAGED IN CLINICAL PRACTICE?
P153 IS IMMIGRANT SCREENING FOR TUBERCULOSIS WORTHWHILE?
P154 OFFERING HIV TESTS IN THE TUBERCULOSIS CLINIC: IMPROVING CLINICAL PRACTICE USING A CONTINUOUS QUALITY IMPROVEMENT PROGRAMME
P155 ONLY TELEPHONE REMINDERS IMPROVE ATTENDENCE AT A TUBERCULOSIS CONTACT TRACING CLINIC
P156 ELISPOT TEST IN DIAGNOSIS OF LATENT TUBERCULOSIS
P157 AUDIT IN THE ROLE OF URINE IN THE DIAGNOSIS OF TUBERCULOSIS
P158 SHORT TERM BLEACH DIGESTION OF SPUTUM IN THE DIAGNOSIS OF PULMONARY TUBERCULOSIS IN PATIENTS CO-INFECTED WITH HIV
P159 ADMINISTRATION OF BCG VACCINATION: SURVEY OF UK PRACTICE
P160 IS CONTACT TRACING OF ANY VALUE FOR FARMERS AND FARM WORKERS WHO HAVE BEEN IN CONTACT WITH BOVINE TUBERCULOSIS?
P161 CONTACT TRACING IN PULMONARY TUBERCULOSIS: A SURVEY OF CURRENT PRACTICE, 2004
P162 RISE IN TUBERCULOSIS NOTIFICATIONS IN HEALTHCARE WORKERS IN AN INDUSTRIAL WESTERN EUROPEAN CITY
P163 INTESTINAL PARASITES AND TUBERCULOSIS IN SOUTHEAST LONDON
P164 EFFECT OF THE INTRODUCTION OF LIQUID CULTURE METHODS ON THE SPEED AND SENSITIVITY OF ISOLATION ON M TUBERCULOSIS: EAST LANCASHIRE 2002–05
P165 CONTEMPORARY USE OF A PROSPECTIVE COMPUTERISED DATABASE IN THORACIC SURGERY: PATIENT AND PRACTICE MANAGEMENT ASPECTS
P166 HALF DECADE OF BIRMINGHAM’S EXPERIENCE IN LOOKING AT SURGICAL RESECTIONS ON PATIENTS WITH STAGE 111 NON-SMALL CELL LUNG CANCER FOLLOWING NEOADJUVANT THERAPY
P167 PREDICTORS OF EARLY DEATH FOLLOWING EXTRAPLEURAL PNEUMONECTOMY FOR MALIGNANT MESOTHELIOMA
P168 CORRELATION OF RADIOLOGICAL AND PLEUROSCOPIC FINDINGS IN PATIENTS WITH HISTOLOGICALLY PROVEN MESOTHELIOMA
P169 APPROPRIATENESS OF VIDEO ASSISTED THORACOSCOPIC SURGERY VERSUS BEDSIDE TALC SLURRY PLEURODESIS IN PATIENTS DYING OF CANCER: JUDGEMENTS OF AN EXPERT PANEL PROCESS
P170 THE IMPACT OF A SPECIALISED PLEURAL PROCEDURES LIST ON DIAGNOSTIC RATES OF BLIND PERCUTANEOUS PLEURAL BIOPSIES: THE END OF THE ABRAMS NEEDLE?
P171 MANAGEMENT OF PRIMARY AND SECONDARY SPONTANEOUS PNEUMOTHORAX
P172 MANAGEMENT WITH CHEST DRAIN: A REGIONAL SURVEY
P173 PNEUMOTHORAX AND THE VALUE OF POST THORACOCENTHESIS RADIOGRAPHY IN A WARD SETTING
P174 THE ROLE OF “BLIND” TRUCUT PLEURAL BIOPSY IN THE INVESTIGATION OF AN EXUDATIVE PLEURAL EFFUSION
P175 IS THE INITIAL FEASIBILITY OF LOBAR LUNG VOLUME REDUCTION SURGERY IN STAGE I NON-SMALL CELL LUNG CANCER JUSTIFIED BY LONG TERM SURVIVAL?
P176 LUNG VOLUME REDUCTION SURGERY FOR EMPHYSEMA: LESSONS LEARNT FROM THE FIRST 100 CASES IN A SINGLE INSTITUTION
P177 MEDIUM TERM FOLLOW UP AFTER DEPLOYMENT OF ULTRAFLEX EXPANDABLE METALLIC STENTS TO MANAGE ENDOBRONCHIAL PATHOLOGY
P178 PREDICTORS OF IDIOPATHIC COUGH: OUTCOME OF A RETROSPECTIVE ANALYSIS
P179 OPIATE THERAPY IN CHRONIC INTRACTABLE COUGH
P180 DETERMINING THE OPTIMUM DOSE OF SLOW RELEASE MORPHINE TO TREAT CHRONIC INTRACTABLE COUGH: OBSERVATIONAL STUDY
P181 ANALYSIS OF COUGH REFLEX SENSITIVITY DATA
P182 AMBULATORY PH MONITORING IS IMPORTANT IN THE DIAGNOSIS AND TREATMENT OF DRY COUGH DUE TO GASTRO-OESOPHAGEAL REFLUX DISEASE
P183 DEXBROMPHENIRAMINE MALEATE INHIBITS CAPSAICIN AND RESINIFERATOXIN ACTIVATION OF TRPV1
P184 THE IMPACT OF PICTURE ARCHIVING AND COMMUNICATION SYSTEMS UPON THE REVIEW AND REPORTING OF CHEST RADIOGRAPHS ON INTENSIVE CARE UNITS IN ENGLAND AND WALES
P185 UTILITY OF ROUTINE CHEST X RAY AFTER UNCOMPLICATED TRANSBRONCHIAL LUNG BIOPSY IN DIAGNOSIS OF PNEUMOTHORAX IN CASES OF DIFFUSE PARENCHYMAL LUNG DISEASE
P186 SHOULD BRONCHOSCOPY BE THE INITIAL INVESTIGATION IN PATIENTS PRESENTING WITH HAEMOPTYSIS AND AN ABNORMAL CHEST X RAY?
P187 SHOULD COMPUTERISED TOMOGRAPHY PRECEDE FIBREOPTIC BRONCHOSCOPY IN A DISTRICT GENERAL HOSPITAL SETTING?
P188 LOCAL ANAESTHESIA FOR FIBREOPTIC BRONCHOSCOPY: TRANSCRICOID INJECTION OR NEBULISATION VIA THE BRONCHOSCOPE?
P189 LOCAL ANAESTHESIA TO THE ANTERIOR NARES BEFORE BRONCHOSCOPY: IMPROVED TOLERABILITY OF LIDOCAINE 5% W/V COMPARED TO XYLOCAINE
P190 RECOLLECTION OF INFORMATION GIVEN DURING CONSENT FOR BRONCHOSCOPY: IS CONSENT STILL VALID?
P191 WHAT IS THE OPTIMUM NUMBER OF TRANSBRONCHIAL BIOPSIES?
P192 UK NATIONAL SURVEY ON ROLE OF TRANSBRONCHIAL LUNG BIOPSY AND BRONCHOALVEOLAR LAVAGE IN THE MANAGEMENT OF DIFFUSE PARENCHYMAL LUNG DISEASE
P193 PERCUTANEOUS TRANSTHORACIC LUNG BIOPSY: THE EXPERIENCE OF A DISTRICT GENERAL HOSPITAL
P194 RANDOMISED CONTROLLED TRIAL COMPARING THE ENK DEVICE WITH CONVENTIONAL ADMINISTRATION OF TOPICAL LIGNOCAINE DURING FLEXIBLE BRONCHOSCOPY
P195 ARTERIALISED EARLOBE BLOOD GAS SAMPLING IN THE UK: STILL AN UNDERUSED TECHNIQUE
P196 THE VALUE OF A NEW CAPNOGRAPHIC DEVICE IN THE ASSESSMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P197 THE REVISED WYTHENSHAWE AMBULATORY OXYGEN PROTOCOL - 2005
P198 EVALUATION OF A TRANSCUTANEOUS CARBON DIOXIDE MONITOR (“TOSCA”) IN ADULT PATIENTS IN ROUTINE RESPIRATORY PRACTICE
P199 EFFECT OF CHANGES IN BLOOD GLUCOSE CONCENTRATION ON GLUCOSE CONCENTRATIONS OF LOWER AIRWAY SECRETIONS SAMPLED BY EXHALED BREATH CONDENSATE
P200 DEVELOPMENT OF AN IN VIVO MODEL OF GLUCOSE CLEARANCE FROM HUMAN AIRWAY SURFACE LIQUID
P201 THE EFFECT OF A PDE4 INHIBITOR (CILOMILAST) ON THE RELEASE OF INFLAMMATORY CYTOKINES FROM AIRWAY EPITHELIAL CELLS
P202 IMPROVING SURVIVAL FROM HIV ASSOCIATED PNEUMOCYSTIS JIROVECII PNEUMONIA ADMITTED TO THE INTENSIVE CARE UNIT
P203 GENOTYPIC VARIATION IN PNEUMOCYSTIS JIROVECII ISOLATES IN BRITAIN
P204 COLONISATION OF THE LUNGS OF BRONCHIECTASIS PATIENTS WITH PSEUDOMONAS AERUGINOSA IS NOT STRONGLY RELATED TO SMOKING OR SEVERITY OF DISEASE
P205 A RAPID TEST FOR MYCOPLASMAL PNEUMONIA
P206 INPATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ACINETOBACTER POSITIVE CLINICAL ISOLATES
P207 HOW GOOD ARE WE IN IMPLEMENTING BTS GUIDELINES IN THE MANAGEMENT OF ADULT COMMUNITY ACQUIRED PNEUMONIA?
P208 THE ROLE OF PLASMA DNA CONCENTRATION AS A PREDICTOR OF MORTALITY AND SEPSIS IN CRITICALLY ILL PATIENTS
P209 KL-6 AS A MARKER OF ALVEOLAR INFLAMMATION IN PATIENTS WITH ARDS
P210 PROTEOMIC COMPARISON OF BRONCHOALVEOLAR LAVAGE AND INDUCED SPUTUM
P211 THE EFFECTS OF NEBULISED BRONCHODILATORS ON METOBONOMIC PROFILE OF EXHALED BREATH CONDENSATE FROM HEALTHY SUBJECTS
P212 METACHOLINE INDUCED REGIONAL VENTILATORY ABNORMALITIES IN NORMAL SUBJECTS
P213 HUMAN LUNG MAST CELLS ADHERE TO HUMAN AIRWAY SMOOTH MUSCLE, IN PART VIA TUMOUR SUPPRESSOR IN LUNG CANCER-1
P214 COOPERATIVE ROLES OF TOLL-LIKE RECEPTORS IN THE INDUCTION OF ANTIVIRAL RESPONSES IN COCULTURES OF AIRWAY SMOOTH MUSCLE CELLS AND LEUKOCYTES
P215 α SMOOTH MUSCLE ACTIN EXPRESSION BY HUMAN AIRWAY SMOOTH MUSCLE CELLS IS UPREGULATED IN CO-CULTURE WITH MAST CELLS
P216 REGULATION OF HUMAN LUNG MAST CELL ION CHANNELS BY ADENOSINE
P217 MAST CELLS EXPRESS IL-13Rα1 AND PRIMING HUMAN LUNG MAST CELLS WITH IL-13 INCREASES FCεRI EXPRESSION AND PROLIFERATION
P218 THE CCR7 LIGAND, CCL19, IS EXPRESSED BY MAST CELLS AND IS CHEMOTACTIC FOR HUMAN AIRWAY SMOOTH MUSCLE CELLS
P219 CCL19 IS EXPRESSED BY ASM IN SEVERE ASTHMA: IMPLICATIONS FOR CHRONIC WOUND REPAIR AND AIRWAY REMODELLING
P220 EXPRESSION OF TRPM7 AND TRPM2 CHANNELS IN HUMAN LUNG MAST CELLS
Author index